Companies: 10,795·Total market cap: $144.5T
Avantor, Inc.

Avantor, Inc.

AVTRNYSEHealthcare● Active
$9.79
+$0.63(+6.88%)
Market Cap$6.7B
P/E Ratio
52W High$15.93
52W Low$7.265

Avantor, Inc. (AVTR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AVTR · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$365.4M +39.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$365.4M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+39.5%
vs prior fiscal year
Latest Quarter
$279.3M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$365.4MCash on Hand
Total Debt$3.95BTotal Debt
Net Cash / Net Debt−$3.58BNet Debt Position
Cash vs Debt Ratio
Cash 8%Debt 92%

Avantor, Inc. carries a net debt position of $3.58B. Total debt ($3.95B) exceeds cash on hand ($365.4M). Avantor, Inc. cash vs debt ratio: 8% cash / 92% debt.

Net Cash = Cash & ST Investments − Total Debt$365.4M$3.95B = −$3.58B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
AVTR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$365.4M+39.5%
Dec 31, 2024$261.9M-0.4%
Dec 31, 2023$262.9M-29.5%
Dec 31, 2022$372.9M+23.6%
Dec 31, 2021$301.7M+5.3%
AVTR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Avantor, Inc.
Avantor, Inc.YOU
AVTR
$365.4M5.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Avantor, Inc. (AVTR) cash on hand as of December 31, 2025 is $365.4M, comprising $365.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Avantor, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Avantor, Inc. cash reserves or cash position.

Avantor, Inc. annual cash on hand history shows increased +39.5% in 2025: increased +39.5% in 2025. Avantor, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Avantor, Inc. carries total debt of $3.95B against cash of $365.4M, resulting in a net debt position of -$3.58B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

AVTR cash on hand · 5 questions

As of December 31, 2025, Avantor, Inc. (AVTR) has $365,400,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $365,400,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $279,300,000. Data sourced from the annual 10-K filing via FMP.

AVTR cash on handAVTR cash reservesAVTR cash 2025how much cash does AVTR have

Source: FMP /balance-sheet-statement · US GAAP · Avantor, Inc. · Avantor, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025